288 related articles for article (PubMed ID: 33602087)
1. Hippocampal and Amygdalar Morphological Abnormalities in Alzheimer's Disease Based on Three Chinese MRI Datasets.
Wei Y; Huang N; Liu Y; Zhang X; Wang S; Tang X
Curr Alzheimer Res; 2020; 17(13):1221-1231. PubMed ID: 33602087
[TBL] [Abstract][Full Text] [Related]
2. The diffeomorphometry of regional shape change rates and its relevance to cognitive deterioration in mild cognitive impairment and Alzheimer's disease.
Tang X; Holland D; Dale AM; Younes L; Miller MI;
Hum Brain Mapp; 2015 Jun; 36(6):2093-117. PubMed ID: 25644981
[TBL] [Abstract][Full Text] [Related]
3. Shape abnormalities of subcortical and ventricular structures in mild cognitive impairment and Alzheimer's disease: detecting, quantifying, and predicting.
Tang X; Holland D; Dale AM; Younes L; Miller MI;
Hum Brain Mapp; 2014 Aug; 35(8):3701-25. PubMed ID: 24443091
[TBL] [Abstract][Full Text] [Related]
4. Regional shape abnormalities in mild cognitive impairment and Alzheimer's disease.
Qiu A; Fennema-Notestine C; Dale AM; Miller MI;
Neuroimage; 2009 Apr; 45(3):656-61. PubMed ID: 19280688
[TBL] [Abstract][Full Text] [Related]
5. Shape and diffusion tensor imaging based integrative analysis of the hippocampus and the amygdala in Alzheimer's disease.
Tang X; Qin Y; Wu J; Zhang M; Zhu W; Miller MI
Magn Reson Imaging; 2016 Oct; 34(8):1087-99. PubMed ID: 27211255
[TBL] [Abstract][Full Text] [Related]
6. APOE Affects the Volume and Shape of the Amygdala and the Hippocampus in Mild Cognitive Impairment and Alzheimer's Disease: Age Matters.
Tang X; Holland D; Dale AM; Miller MI;
J Alzheimers Dis; 2015; 47(3):645-60. PubMed ID: 26401700
[TBL] [Abstract][Full Text] [Related]
7. One-year Follow-up Study of Hippocampal Subfield Atrophy in Alzheimer's Disease and Normal Aging.
Madusanka N; Choi HK; So JH; Choi BK; Park HG
Curr Med Imaging Rev; 2019; 15(7):699-709. PubMed ID: 32008518
[TBL] [Abstract][Full Text] [Related]
8. Volume changes of hippocampal and amygdala subfields in patients with mild cognitive impairment and Alzheimer's disease.
Qu H; Ge H; Wang L; Wang W; Hu C
Acta Neurol Belg; 2023 Aug; 123(4):1381-1393. PubMed ID: 37043115
[TBL] [Abstract][Full Text] [Related]
9. Amygdalar and Hippocampal Morphometry Abnormalities in First-Episode Schizophrenia Using Deformation-Based Shape Analysis.
Tang X; Lyu G; Chen M; Huang W; Lin Y
Front Psychiatry; 2020; 11():677. PubMed ID: 32765318
[TBL] [Abstract][Full Text] [Related]
10. Hippocampal Stratum Radiatum, Lacunosum, and Moleculare Sparing in Mild Cognitive Impairment.
Su L; Hayes L; Soteriades S; Williams G; Brain SAE; Firbank MJ; Longoni G; Arnold RJ; Rowe JB; O'Brien JT
J Alzheimers Dis; 2018; 61(1):415-424. PubMed ID: 29171994
[TBL] [Abstract][Full Text] [Related]
11. Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum.
Allison SL; Koscik RL; Cary RP; Jonaitis EM; Rowley HA; Chin NA; Zetterberg H; Blennow K; Carlsson CM; Asthana S; Bendlin BB; Johnson SC
Neuroimage Clin; 2019; 23():101895. PubMed ID: 31252287
[TBL] [Abstract][Full Text] [Related]
12. Deformation-based Statistical Shape Analysis of the Corpus Callosum in Mild Cognitive Impairment and Alzheimer's Disease.
Jiang Z; Yang H; Tang X
Curr Alzheimer Res; 2018; 15(12):1151-1160. PubMed ID: 30101708
[TBL] [Abstract][Full Text] [Related]
13. A pilot study of brain morphometry following donepezil treatment in mild cognitive impairment: volume changes of cortical/subcortical regions and hippocampal subfields.
Kim GW; Kim BC; Park KS; Jeong GW
Sci Rep; 2020 Jul; 10(1):10912. PubMed ID: 32616841
[TBL] [Abstract][Full Text] [Related]
14. Non-linear registration improves statistical power to detect hippocampal atrophy in aging and dementia.
Bartel F; Visser M; de Ruiter M; Belderbos J; Barkhof F; Vrenken H; de Munck JC; van Herk M;
Neuroimage Clin; 2019; 23():101902. PubMed ID: 31233953
[TBL] [Abstract][Full Text] [Related]
15. Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease.
Yi HA; Möller C; Dieleman N; Bouwman FH; Barkhof F; Scheltens P; van der Flier WM; Vrenken H
J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):425-32. PubMed ID: 25904810
[TBL] [Abstract][Full Text] [Related]
16. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.
Apostolova LG; Dutton RA; Dinov ID; Hayashi KM; Toga AW; Cummings JL; Thompson PM
Arch Neurol; 2006 May; 63(5):693-9. PubMed ID: 16682538
[TBL] [Abstract][Full Text] [Related]
17. Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer's disease.
Younes L; Albert M; Miller MI;
Neuroimage Clin; 2014; 5():178-87. PubMed ID: 25101236
[TBL] [Abstract][Full Text] [Related]
18. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
[TBL] [Abstract][Full Text] [Related]
19. Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.
Morra JH; Tu Z; Apostolova LG; Green AE; Avedissian C; Madsen SK; Parikshak N; Hua X; Toga AW; Jack CR; Schuff N; Weiner MW; Thompson PM;
Hum Brain Mapp; 2009 Sep; 30(9):2766-88. PubMed ID: 19172649
[TBL] [Abstract][Full Text] [Related]
20. Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort.
Risacher SL; Saykin AJ; West JD; Shen L; Firpi HA; McDonald BC;
Curr Alzheimer Res; 2009 Aug; 6(4):347-61. PubMed ID: 19689234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
